Labroots12h
GLP1-RA drugs used for diabetes and weight loss may have a positive role in addiction as well
Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...
WebMD18h
New Guidance for Patients Taking GLP-1 Drugs Before Surgery
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.
CBS19 News18h
Virginia Residents Are Using GLP-1s at a Below Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Gwinnett Daily Post19h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
KSJB AM20h
U.S. Obesity Market Analysis: Exploring Demographic & Geographic Disparities in GLP-1 Use
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Southern Minn21h
Iowa Has the 9th Highest Rate of GLP-1 Use in the Country
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Southern Minn21h
Minnesota Has the 13th Lowest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
The Digital Courier21h
North Carolina Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Iosco County News-Herald21h
Michigan Residents Are Using GLP-1s at the 6th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...